Incyte Corp (INCY)
77.29
+1.54
(+2.03%)
USD |
NASDAQ |
Nov 05, 16:00
77.29
0.00 (0.00%)
After-Hours: 16:28
Incyte Max Drawdown (5Y): 58.61% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 58.61% |
| September 30, 2024 | 58.61% |
| August 31, 2024 | 58.61% |
| July 31, 2024 | 58.61% |
| June 30, 2024 | 58.61% |
| May 31, 2024 | 58.61% |
| April 30, 2024 | 58.61% |
| March 31, 2024 | 58.61% |
| February 29, 2024 | 58.61% |
| January 31, 2024 | 58.61% |
| December 31, 2023 | 58.61% |
| November 30, 2023 | 58.61% |
| October 31, 2023 | 58.61% |
| September 30, 2023 | 61.68% |
| August 31, 2023 | 61.68% |
| July 31, 2023 | 61.68% |
| June 30, 2023 | 61.68% |
| May 31, 2023 | 61.68% |
| April 30, 2023 | 61.68% |
| March 31, 2023 | 61.68% |
| February 28, 2023 | 61.68% |
| January 31, 2023 | 61.68% |
| December 31, 2022 | 61.68% |
| November 30, 2022 | 61.68% |
| October 31, 2022 | 61.68% |
| Date | Value |
|---|---|
| September 30, 2022 | 61.68% |
| August 31, 2022 | 61.68% |
| July 31, 2022 | 61.68% |
| June 30, 2022 | 61.68% |
| May 31, 2022 | 61.68% |
| April 30, 2022 | 61.68% |
| March 31, 2022 | 61.68% |
| February 28, 2022 | 61.68% |
| January 31, 2022 | 61.68% |
| December 31, 2021 | 61.68% |
| November 30, 2021 | 61.68% |
| October 31, 2021 | 61.68% |
| September 30, 2021 | 61.68% |
| August 31, 2021 | 61.68% |
| July 31, 2021 | 61.68% |
| June 30, 2021 | 61.68% |
| May 31, 2021 | 61.68% |
| April 30, 2021 | 61.68% |
| March 31, 2021 | 61.68% |
| February 28, 2021 | 61.68% |
| January 31, 2021 | 61.68% |
| December 31, 2020 | 61.68% |
| November 30, 2020 | 61.68% |
| October 31, 2020 | 61.68% |
| September 30, 2020 | 61.68% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
58.61%
Minimum
Oct 2023
61.68%
Maximum
Nov 2019
61.02%
Average
61.68%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Syndax Pharmaceuticals Inc | 61.18% |
| Merck & Co Inc | 27.26% |
| Pfizer Inc | 54.78% |
| Biomarin Pharmaceutical Inc | 52.14% |
| Allogene Therapeutics Inc | 96.15% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -13.96 |
| Beta (5Y) | 0.7084 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 31.54% |
| Historical Sharpe Ratio (5Y) | -0.1527 |
| Historical Sortino (5Y) | -0.3188 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 12.71% |